Zimmermann-Paiz MA, Fang-Sung JW, Porras-Jui DK, Cotto-Menchú EJ, Romero-Escribá AL

Language: Spanish
References: 14
Page: 323-326
PDF size: 80.42 Kb.

ABSTRACT

Introduction: Retinopathy of prematurity is emerging in Guatemala as an important cause of blindness, potentially preventable and treatable.
Materials and methods: During February 2008 to January 2009, 74 premature neonates born at San Juan de Dios General Hospital located at the capital city of Guatemala were examined. Patients with the following criteria were included: birth weight ≤1750 g and/or gestational age ≤34 weeks, birth weight ›1750 g and/or gestational age ›34 weeks at the discretion of the neonatologist.
Results: 18 patients (24.32%) with retinopathy of prematurity were found.
Conclusions: The observed characteristics suggest that all the patients with less than 37 weeks of gestation and/or weight less than 2000 grams should be evaluated and that a rigorous protocol for the use of inhaled oxygen should be elaborated.

REFERENCES

1. Gilbert C, Foster A. Childhood blindness in the context of Vision 2020-The Right to Sight. Bull World Health Organ, 2001; 79(3):227-232.

2. Gilbert CE y cols. Prevalence of blindness and visual impairment in children -a review of available data. Ophthalmic Epidemiology, 1999; 6:73-81.

3. Muñoz B, West SK. Blindness and visual impairment in the Americas and Caribbean. Br J Ophthalmol 2002; 86:498-504.

4. Gilbert C, Fielder A, Gordillo L, Quinn G, Semiglia R, Visintin P, Zin A. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: Implications for screening programs. Pediatrics 2005; 5(115):518-525.

5. Grupo de Trabajo colaborativo Multicéntrico: “Prevención de la ceguera en la infancia por retinopatía del prematuro (RDP)”. Retinopatía del prematuro en servicios de neonatología de Argentina. Arch Argent Pediatr 2006; 104(1):69-74.

6. www.v2020la.org. Pautas para el examen, detección, y tratamiento de retinopatía del prematuro en países de Latinoamérica, IAPB.

7. An international committee for the classification of retinopathy of prematurity. The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 2005; 123:991-999.

8. Early treatment for retinopathy of prematurity cooperative group. Revised indications for the treatment of retinopathy of prematurity. Arch Ophthalmol 2003; 121:1684-1696.

9. Lutty GA, Chang-Ling T, Phelps DL, Adamis AP, Bears KI y cols. Proceedings of the third international symposium on retinopathy of prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). Molecular Vision 2006; 12:532-580.

10. Section on Ophthalmology, American Academy of Pediatrics, American Academy of Ophthalmology and American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2006; 117:572-576.

11. Wilkinson AR, Haines L, Head K, Fielder AR. UK retinopathy of prematurity guideline. Londres. Royal College of Paediatrics and Child Health, 2008.

12. Che Y, Li X, Yin H, Gilbert C, Liang J, Jiang Y, Zhao M. Risk factors for retinopathy of prematurity in six neonatal intensive care units in Beijing, China. Br J Ophthalmol 2008; 92:326-331.

13. Vinekar A, Dogra MR, Sangtam T, Narang A, Gupta A. Retinopathy of prematurity in Asian Indian babies weighing greater than 1250 grams at birth: Ten year data from a tertiary care center in a developing country. Indian J Ophthalmol 2007; 55:331-336.

14. Lad EM, Nguyen TC, Morton JM, Moshfeghi DM. Retinopathy of prematurity in the United States. Br J Ophthalmol 2008; 92:320-325.